RYTM

$0.00

(

+0.00%

)
Quote details

stock

Rhythm Pharmaceuticals Inc

NASDAQ | RYTM

117.62

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 11, 2025)

$6.99B

Market Cap

-

P/E Ratio

-3.1

EPS

$122.20

52 Week High

$45.91

52 Week Low

HEALTHCARE

Sector

RYTM Chart

Recent Chart
Price Action

RYTM Technicals

Tags:

RYTM Earnings

Earnings Performance

RYTM Financials

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$114M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -$10M
Profit Loss -
Cashflow From Investment -$48M
Cashflow From Financing $191M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $4M
Dividend Payout Common Stock $4M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$261M

RYTM News

RYTM Profile

Rhythm Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rhythm Pharmaceuticals, Inc. is a Boston-based biopharmaceutical innovator focused on developing groundbreaking therapies for rare genetic obesity disorders. The company's flagship product, Imcivree (setmelanotide), targets the underlying biological mechanisms of severe obesity associated with specific genetic conditions, providing critical treatment options for an underserved patient demographic. Leveraging its expertise in melanocortin system research, Rhythm is poised to expand its pipeline, further enhancing patient outcomes and quality of life, and reinforcing its leadership position at the intersection of genetic medicine and metabolic health.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.